Login
$OBIO
$7.12 +$0.00 (0.0%) After hours

$OBIO SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 SCHEDULE 13D/A
12 Nov 2026 Form 4: Rtw INVESTMENTS, Lp, 10% owner and 1 other

Bought 1,200,000 shares ($6M)

10 Nov 2026 10-Q
09 Nov 2026 Form 4: Fain Eric S, Director

Bought 20,000 shares ($100K)

09 Nov 2026 Form 4: Pacitti David, Director

Bought 20,000 shares ($100K)

09 Nov 2026 Form 4: Hochman David P, Director

Bought 5,000 shares ($25K)

09 Nov 2026 Form 4: Taylor Andrew Lawrence, Chief Financial Officer

Bought 1,000 shares ($5K)

09 Nov 2026 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

Orchestra BioMed Holdings, Inc., a Delaware corporation (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 15,000,000 shares (the “Firm Shares”) of Common Stock, ...

06 Nov 2026 424B5
05 Nov 2026 424B5
03 Nov 2026 Form 4: Sherman Darren, Director

Sold 15,000 shares ($86.1K)

02 Nov 2026 144
02 Oct 2026 Form 4: Sherman Darren, Director

Sold 15,000 shares ($95.4K)

01 Oct 2026 144
01 Oct 2026 8-K: Regulation FD Disclosure; Other Events

330 patients randomized as of September 30, 2026, surpassing full trial enrollment target

11 Sep 2026 Form 4: Hochman David P, Director

Gave up 3,283 shares to cover exercise price or tax ($19.1K) · Gave up 3,283 shares to cover exercise price or tax ($19.1K)

08 Sep 2026 8-K: Regulation FD Disclosure

Accelerating high - impact technologies to patients through risk - reward sharing partnerships Corporate Overview | September 2026 Nasdaq : OBIO

08 Sep 2026 Form 4: Hochman David P, Director

Bought 10,000 shares ($47.9K)

02 Sep 2026 Form 4: Sherman Darren, Director

Sold 15,000 shares ($74.1K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support